Dr. Jiaxue Huang — Visionary Scientist and Pioneer in Stem Cell and Genomic Medicine

Dr. Jiaxue Huang is a distinguished biologist, immunologist, and entrepreneur whose pioneering work has reshaped the landscape of genomics, stem cell research, and personalized medicine. As the Founder and Chairman of Jiaxue Gene Technology (Beijing) Co., Ltd., Dr. Huang has dedicated his career to unlocking the secrets of the human genome and harnessing genetic intelligence to promote predictive, preventive, and truly personalized healthcare.

Academic Foundation and Scientific Pedigree

Dr. Huang’s scientific rigor is grounded in a robust academic background spanning biology, biochemistry, and immunology.
He earned his Bachelor’s degree in Biology from Hubei University in 1990, followed by a Master’s in Biochemistry and Biophysics from Wuhan University in 1997. In 2005, he obtained his Ph.D. in Immunology from the University of Oklahoma Health Sciences Center, where he trained under renowned immunologist Professor Paul Kincade, past president of the American Association of Immunologists (AAI) and the Federation of American Societies for Experimental Biology (FASEB). His doctoral research on lymphocyte development and immune regulation laid the foundation for his lifelong pursuit of understanding cellular and genetic mechanisms of health and disease.

Professional Journey and Leadership

Following his Ph.D., Dr. Huang joined Novartis Pharmaceuticals’ Genomics Research Center as a Postdoctoral Researcher (2005–2008), where he contributed to high-throughput drug screening and antibody development, including a therapeutic candidate targeting breast cancer stem cells that advanced to clinical trials.
From 2008 to 2014, he served as Technical General Manager and Vice President of Technology at Zhongyuan Union Stem Cell Bioengineering Co., Ltd., leading research on hematopoietic, mesenchymal, and tumor stem cells. During this period, he also held professorial appointments at Tianjin University’s School of Pharmaceutical Science and Technology and East China University of Science and Technology, nurturing the next generation of biotechnology innovators.

Dr. Huang’s leadership and scientific credibility earned him election as Asia-Pacific President of the International Society for Cellular Therapy (ISCT) from 2011 to 2013. In 2014, driven by his vision to translate cutting-edge science into practical healthcare solutions, he founded Jiaxue Gene, which has since become a leader in genomic decoding and precision diagnostics in China.

Scientific Contributions and Innovations

Dr. Huang’s contributions span several interrelated fields:

• Stem Cell Research and Regenerative Medicine: He has elucidated mechanisms of lymphocyte differentiation and developed techniques for the in-vitro transformation of adult bone marrow stem cells into functional T cells. He also pioneered industrial-scale adipose stem cell systems and protocols for differentiating these cells into osteoblasts, adipocytes, and insulin-producing cells. His work has led to multiple patents, including methods for isolating and expanding umbilical cord, placental, and adipose-derived stem cells.

• Gene Decoding and Genetic Testing: Dr. Huang invented the “Gene Decoding Technology System,” a next-generation platform that transcends traditional sequencing by decoding functional genomic patterns. Under his leadership, Jiaxue Gene has advanced applications in hereditary disease risk assessment, pharmacogenomics, prenatal and neonatal screening, talent and trait identification, and personalized wellness programs.

• High-Throughput Drug Discovery: Earlier in his career at the Chinese Academy of Medical Sciences’ Institute of Materia Medica, Dr. Huang played a central role in establishing China’s first high-throughput drug screening center, laying the groundwork for modern precision pharmacology in the country.

Honors and Recognition

Dr. Huang’s excellence has been recognized through numerous awards, including the Ph.D. Graduate with Academic Excellence Award (USA, 2005), the GSA Travel Award (2005), and the Chinese Medical Science and Technology Award and Beijing Science and Technology Second Prize (2002) for his contributions to high-throughput screening technology. His portfolio includes multiple authorized patents related to stem cell culture systems and cell differentiation detection kits.

Philosophy and Vision

A scientist with a humanitarian vision, Dr. Huang believes that genomics and stem cell technologies should empower individuals through knowledge, prevention, and personalized care. He advocates a paradigm shift from reactive disease treatment to genetically guided health management, where understanding one’s DNA leads to informed lifestyle and medical choices.

Through his innovative leadership at Jiaxue Gene, Dr. Huang continues to bridge the gap between frontier science and clinical application. His lifelong mission—to decode the blueprint of life and transform it into actionable health intelligence—has positioned him as a transformative force in global precision medicine and a guiding light for the next generation of biomedical innovation.